Indian Generics Also Suffer Slowdown In U.S. Economy
This article was originally published in PharmAsia News
Executive Summary
New data suggests Indian generics makers suffered to a large extent in the downturn in the U.S. economy in 2008. According to IMS Health Retail Drug Monitor, drugstore sales in the United States grew by only one percent last year, an important figure since the country accounts for half of the global pharmaceutical market. But generics makers are expected to profit in general because a weaker economy leads to greater emphasis on generics over branded drugs. The large European market rose by two percent during the period ending in October of last year and emerging markets demonstrated a better growth in sales. (Click here for more